Kai Wucherpfennig
InvestorStrategic Advisory Board at Longwood Fund · Board director at Immunitas Therapeutics
Find your path to Kai
54 people in our graph share verified history with Kai — schools, employers, funds. One of them is your warm intro.
Christoph WestphalunlockedKai: together at Longwood Fund
×11Kai: together at Longwood Fund
About
Chair of Cancer Immunology and Virology at Dana-Farber, Harvard faculty, and scientific co-founder of Immunitas.
Board director at Immunitas Therapeutics
Intro paths
→
In turn, Kai can intro founders to Immunitas Therapeutics's investors below.
Immunitas Therapeutics's investors · 9
Agent CapitalWaltham · since 2021DC Investment PartnersMcLean · $10M checks · since 2021Leaps by BayerLeverkusen · since 2021Longwood FundBoston · since 2021M VenturesLos Angeles · $10.8M checks · since 2021Medical Excellence CapitalNew York · since 2021Novartis Venture FundBasel · $5M – $25M checks · since 2021Ono Venture Investment, Inc.South San Francisco · since 2021Solasta VenturesBoston · since 2021
Colleagues at Longwood Fund
Al Sandrock
Strategic Advisory Board at Longwood Fund
Aleks Radovic-Moreno
Partner at Longwood Fund
Alex Margolin
Venture Partner at Longwood Fund
Annalisa D'Andrea
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund
Arielle Jackson
Head, Corporate Communications & Industry Engagement at Longwood Fund
Frequently asked questions
- Who is Kai Wucherpfennig?
- Chair of Cancer Immunology and Virology at Dana-Farber, Harvard faculty, and scientific co-founder of Immunitas.
- Where does Kai Wucherpfennig work?
- Kai Wucherpfennig is Strategic Advisory Board at Longwood Fund and Board director at Immunitas Therapeutics.